Nurulimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Nurulimab Usage And Synthesis

Uses

Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma[1].

References

[1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 34, No. 1, 2020.

Nurulimab(2168561-20-2)Related Product Information

• Balstilimab
• Enokizumab
• Batoclimab
• Brodalumab
• Inebilizumab
• Mavrilimumab
• Varisacumab
• Denosumab
• Elezanumab
• Crotedumab